FIRST AMENDED AND RESTATED LICENSE AGREEMENTConfidential Treatment • June 10th, 2016 • Kadmon Holdings, LLC • Pharmaceutical preparations • New York
Contract Type FiledJune 10th, 2016 Company Industry JurisdictionThis FIRST AMENDED AND RESTATED LICENSE AGREEMENT (the “Agreement”), dated as of September , 2011 (the “Execution Date”) and effective as of August 13, 2010 (the “Effective Date”) by and between Symphony Evolution, Inc., a Delaware corporation (“Symphony”) and Kadmon Corporation, LLC (f/k/a Kadmon Pharmaceuticals, LLC), a Delaware limited liability company (“Licensee”) (each of Symphony and Licensee being a “Party,” and collectively, the “Parties”).
FIRST AMENDED AND RESTATED LICENSE AGREEMENTConfidential Treatment • March 18th, 2016 • Kadmon Holdings, LLC • Pharmaceutical preparations • New York
Contract Type FiledMarch 18th, 2016 Company Industry JurisdictionThis FIRST AMENDED AND RESTATED LICENSE AGREEMENT (the “Agreement”), dated as of September , 2011 (the “Execution Date”) and effective as of August 13, 2010 (the “Effective Date”) by and between Symphony Evolution, Inc., a Delaware corporation (“Symphony”) and Kadmon Corporation, LLC (f/k/a Kadmon Pharmaceuticals, LLC), a Delaware limited liability company (“Licensee”) (each of Symphony and Licensee being a “Party,” and collectively, the “Parties”).